Antimicrobial resistance grants
This article was originally published in The Tan Sheet
Executive Summary
CDC announces availability of roughly $600,000 in grant funding for fiscal 2002 for applied research aimed at "prevention and control of the emergence and spread of antimicrobial resistance" in U.S. Program will focus on validation of National Committee for Clinical Laboratory Standards breakpoints for human pathogens of public health importance, according to June 4 Federal Register notice. Research, in form of three separate $200,000 grants, is expected to begin Aug. 30 and continue for up to three years, CDC says. Completed application forms, available on 1CDC Web site, are due July 16...
You may also be interested in...
Robust Trial Transparency Strategy Boosts Patient Engagement
Most clinical trial sponsors view data disclosure as a mandate, maintaining regulatory compliance as a legal requirement. Study sponsors that realize the potential to repurpose this data, using a patient-first approach, turn transparency into a strategic advantage for engagement and recruitment efforts.
Medtronic’s Perfusion System Recall Is The 5th In 2 Months
The Bio-Console 560 extracorporeal blood pumping console is being recalled over reports it could lose power during bypass surgery, which could lead to organ or neural dysfunction, blood clots, or even death.
US House Co-signs Banking For Hemp Industry
House passes “SAFE Banking” Act sponsored by Rep. Ed Perlmutter to allow cannabis- and hemp-related businesses in states with some form of legalized marijuana to access financial services by creating protections for those institutions. Sen. Jeff Merkley introduced the same legislation in March.